OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.230
+0.010 (0.82%)
At close: Apr 24, 2026, 4:00 PM EDT
1.220
-0.010 (-0.81%)
After-hours: Apr 24, 2026, 7:55 PM EDT
OPKO Health Stock Forecast
Stock Price Forecast
The 2 analysts that cover OPKO Health stock have a consensus rating of "Hold" and an average price target of $1.55, which forecasts a 26.02% increase in the stock price over the next year. The lowest target is $1.50 and the highest is $1.60.
Price Target: $1.55 (+26.02%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 2, 2026.
Analyst Ratings
The average analyst rating for OPKO Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $2.25 → $1.5 | Buy | Maintains | $2.25 → $1.5 | +21.95% | Mar 2, 2026 |
| JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 20, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $2 → $1.6 | Strong Buy → Hold | Downgrades | $2 → $1.6 | +30.08% | Oct 31, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +82.93% | Oct 30, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +82.93% | May 1, 2025 |
Financial Forecast
Revenue This Year
556.73M
from 606.88M
Decreased by -8.26%
Revenue Next Year
580.33M
from 556.73M
Increased by 4.24%
EPS This Year
-0.28
from -0.30
EPS Next Year
-0.25
from -0.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 613.6M | 620.0M | ||||||
| Avg | 556.7M | 580.3M | ||||||
| Low | 531.2M | 550.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.1% | 11.4% | ||||||
| Avg | -8.3% | 4.2% | ||||||
| Low | -12.5% | -1.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.22 | -0.11 | |
| Avg | -0.28 | -0.25 | |
| Low | -0.33 | -0.32 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.